In GBM, the expression of the EGFRvIII variant has been correlated to the activation of SK1 [46] and to increased levels of extracellular S1P [31]; moreover, it has been shown that increased SK1 expression and S1P formation, transactivate EGFR signaling pathway [47]. The gene discussed is MBTPS1; the disease is glioblastoma.